HU183046B - Process for producing hydanthoine derivatives - Google Patents
Process for producing hydanthoine derivatives Download PDFInfo
- Publication number
- HU183046B HU183046B HU77WE560A HUWE000560A HU183046B HU 183046 B HU183046 B HU 183046B HU 77WE560 A HU77WE560 A HU 77WE560A HU WE000560 A HUWE000560 A HU WE000560A HU 183046 B HU183046 B HU 183046B
- Authority
- HU
- Hungary
- Prior art keywords
- formula
- priority
- compound
- reaction
- june
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
- C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/72—Two oxygen atoms, e.g. hydantoin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/72—Two oxygen atoms, e.g. hydantoin
- C07D233/76—Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
- C07D233/78—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/86—Oxygen and sulfur atoms, e.g. thiohydantoin
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB2287776 | 1976-06-03 | ||
GB5034076 | 1976-12-02 | ||
GB1214577 | 1977-03-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
HU183046B true HU183046B (en) | 1984-04-28 |
Family
ID=27256793
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU77WE560A HU183046B (en) | 1976-06-03 | 1977-06-02 | Process for producing hydanthoine derivatives |
Country Status (12)
Country | Link |
---|---|
JP (1) | JPS52151168A (de) |
CA (1) | CA1176261A (de) |
CH (3) | CH645631A5 (de) |
DE (1) | DE2724948A1 (de) |
DK (1) | DK244577A (de) |
ES (5) | ES459412A1 (de) |
FI (1) | FI71930C (de) |
FR (1) | FR2362839A1 (de) |
HU (1) | HU183046B (de) |
NL (1) | NL7706064A (de) |
NZ (1) | NZ184281A (de) |
SE (2) | SE446336B (de) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1602188A (en) * | 1977-12-01 | 1981-11-11 | Wellcome Found | Hydantoin derivatives |
IE48747B1 (en) * | 1977-09-05 | 1985-05-15 | Wellcome Found | Hydantoin derivatives |
AU531493B2 (en) * | 1977-12-01 | 1983-08-25 | The Wellcome Foundation Limited | Thiohydantion derivatives |
EP0003410B1 (de) * | 1978-01-23 | 1982-10-06 | Beecham Group Plc | Hydantoine und Thiohydantoine, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen |
EP0004723A1 (de) * | 1978-03-30 | 1979-10-17 | Beecham Group Plc | Deoxyhydantoine, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen |
GB1599740A (en) * | 1978-05-31 | 1981-10-07 | Wellcome Found | Hydantoin derivatives |
IL57504A0 (en) * | 1978-06-15 | 1979-10-31 | Beecham Group Ltd | Prostagandin analogues,their preparation and pharmaceutical compositions containing |
AU4806979A (en) * | 1978-06-15 | 1979-12-20 | Beecham Group Limited | 1,2,4 triazole derivatives |
AU4778279A (en) * | 1978-06-15 | 1979-12-20 | Beecham Group Limited | Prostaglandin analogues |
EP0006352A1 (de) * | 1978-06-15 | 1980-01-09 | Beecham Group Plc | Hydantoine und Thiohydantoine, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen |
IL59065A0 (en) * | 1979-01-18 | 1980-05-30 | Beecham Group Ltd | Hydantoin derivatives,their preparation pharmaceutical compositons containing them |
EP0019223A1 (de) * | 1979-05-09 | 1980-11-26 | The Wellcome Foundation Limited | Optisch aktive Hydantoinderivate, ihre Herstellung, sie enthaltende pharmazeutische Formulierungen und Zwischenprodukte |
US4684735A (en) * | 1985-07-01 | 1987-08-04 | Stauffer Chemical Company | Promotion of raney nickel hydrogenation catalyst |
JP3022878U (ja) * | 1995-08-18 | 1996-04-02 | 有限会社春江加工 | ミニディスク用ケース |
AU2002356927A1 (en) * | 2001-11-30 | 2003-06-17 | Eli Lilly And Company | Peroxisome proliferator activated receptor agonists |
US7179820B2 (en) * | 2003-06-06 | 2007-02-20 | Allergan, Inc. | Piperidinyl prostaglandin E analogs |
JP2006527189A (ja) * | 2003-06-06 | 2006-11-30 | アラーガン、インコーポレイテッド | ピペリジニルプロスタグランジンe類似体 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1524818A (en) * | 1974-11-29 | 1978-09-13 | Beecham Group Ltd | 12-azaprostaglandins |
-
1977
- 1977-06-02 CH CH679677A patent/CH645631A5/de not_active IP Right Cessation
- 1977-06-02 SE SE7706428A patent/SE446336B/xx unknown
- 1977-06-02 DE DE19772724948 patent/DE2724948A1/de not_active Ceased
- 1977-06-02 FR FR7716849A patent/FR2362839A1/fr active Granted
- 1977-06-02 NZ NZ184281A patent/NZ184281A/xx unknown
- 1977-06-02 FI FI771763A patent/FI71930C/fi not_active IP Right Cessation
- 1977-06-02 DK DK244577A patent/DK244577A/da not_active Application Discontinuation
- 1977-06-02 NL NL7706064A patent/NL7706064A/xx not_active Application Discontinuation
- 1977-06-02 ES ES459412A patent/ES459412A1/es not_active Expired
- 1977-06-02 CA CA000280455A patent/CA1176261A/en not_active Expired
- 1977-06-02 HU HU77WE560A patent/HU183046B/hu unknown
- 1977-06-02 JP JP6525277A patent/JPS52151168A/ja active Granted
-
1978
- 1978-06-01 ES ES470428A patent/ES470428A1/es not_active Expired
-
1979
- 1979-02-28 ES ES478156A patent/ES478156A1/es not_active Expired
- 1979-06-28 ES ES482010A patent/ES482010A1/es not_active Expired
-
1980
- 1980-03-25 ES ES489883A patent/ES8103057A1/es not_active Expired
-
1982
- 1982-05-19 SE SE8203161A patent/SE8203161L/sv not_active Application Discontinuation
-
1984
- 1984-02-07 CH CH57784A patent/CH646426A5/de not_active IP Right Cessation
- 1984-02-07 CH CH576/84A patent/CH647511A5/de not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
SE446336B (sv) | 1986-09-01 |
CA1176261A (en) | 1984-10-16 |
NL7706064A (nl) | 1977-12-06 |
ES489883A0 (es) | 1981-02-16 |
FI71930B (fi) | 1986-11-28 |
CH647511A5 (en) | 1985-01-31 |
FI771763A (fi) | 1977-12-04 |
FR2362839A1 (fr) | 1978-03-24 |
ES459412A1 (es) | 1978-11-01 |
FR2362839B1 (de) | 1980-02-01 |
ES8103057A1 (es) | 1981-02-16 |
DK244577A (da) | 1977-12-04 |
NZ184281A (en) | 1980-04-28 |
SE7706428L (sv) | 1977-12-04 |
CH645631A5 (en) | 1984-10-15 |
SE8203161L (sv) | 1982-05-19 |
ES478156A1 (es) | 1979-11-01 |
FI71930C (fi) | 1987-03-09 |
ES470428A1 (es) | 1979-09-01 |
CH646426A5 (en) | 1984-11-30 |
ES482010A1 (es) | 1980-08-16 |
DE2724948A1 (de) | 1977-12-15 |
JPS52151168A (en) | 1977-12-15 |
JPS6222986B2 (de) | 1987-05-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HU183046B (en) | Process for producing hydanthoine derivatives | |
US4581370A (en) | Antiarrhythmic imidazoliums | |
JP3162532B2 (ja) | フェノキシ酢酸誘導体 | |
DE69522676T2 (de) | Naphtalen-derivate als prostaglandin i2 agonisten | |
PL166582B1 (pl) | Sposób wytwarzania nowych pochodnych amin aromatycznych PL PL | |
US4672066A (en) | Derivatives of 4-acetyl-3-hydroxy-2-alkyl-phenoxycarboxylic acids | |
US4857644A (en) | Aryl sulfonopiperazines as anti-inflammatory agents | |
US4413006A (en) | N-Aryl-N-phenoxy-alkyl-piperazine compounds useful in decreasing intracranial pressure | |
US5705523A (en) | Pyridine- and imidazole-derived agents for cardiovascular diseases | |
US4486443A (en) | Hydantoin derivatives and pharmaceutical use | |
EP0001238B1 (de) | Hydantoinderivate, deren Herstellung, sowie diese Verbindungen enthaltende Arzneimittel, und deren Zwischenprodukte | |
US4341789A (en) | Cycloaliphatic prostaglandin analogues | |
US5001140A (en) | Cycloalkylthiazoles | |
KR20010101818A (ko) | (1-페나시-3-페닐-3-피페리딜에틸)피페리딘 유도체, 그의제조 방법 및 이를 함유하는 제약 조성물 | |
US4613609A (en) | Antiarrhythmic imidazoliums | |
RU2049776C1 (ru) | Производное хинона или его фармакологически приемлемые соли | |
US4665080A (en) | Imidazolyl compounds and their use as medicaments | |
US4371696A (en) | Certain pyridine methylthio acetaldehyde derivatives and non-cyclic and cyclic acetals thereof | |
EP0090275A2 (de) | Isoxazole (5,4-b) Pyridine | |
US4888352A (en) | 3,4, or 5-aryl-1H-pyrazole-1-alkanamides as antiarrhythmic agents, compositions and use | |
US4201864A (en) | Oxy-alkylamino acids and esters | |
US4177283A (en) | Aromatic prostaglandin analogues | |
US4262128A (en) | Nitrogen heterocycles | |
US4500535A (en) | Method of regulating the immune response with pyridine derivatives | |
GB1595694A (en) | Hyantoin analogues |